Endeavour Silver (EXK) delivered earnings and revenue surprises of 0.00% and +5.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Avino Silver (ASM) Suffers a Larger Drop Than the General Market: Key Insights
Avino Silver (ASM) reached $5.27 at the closing of the latest trading day, reflecting a -4.18% change compared to its last close.
Zacks
Avino Silver (ASM) Declines More Than Market: Some Information for Investors
In the latest trading session, Avino Silver (ASM) closed at $5.69, marking a -9.11% move from the previous day.
Zacks
Here's Why You Should Retain Cabot Stock in Your Portfolio for Now
CBT's battery materials momentum, portfolio expansion and cost actions support growth despite weak tire demand and near-term cash-flow pressure.
Zacks
BASFY Boosts BMB Additives Portfolio for Architectural Coatings
BASF expands its certified biomass-balanced additives portfolio, helping coatings makers cut carbon footprints without sacrificing performance or reformulation.
Zacks
AVNT's Dyneema DM20 Fiber Earns ClassNK Approval for FOWT Applications
Avient's Dyneema DM20 fiber gains ClassNK approval for floating offshore wind mooring systems, supporting wider adoption in Japan's expanding market.
Zacks
Fortuna Mining's H1 Gold-Equivalent Production Hits 145,089 Ounces
FSM's H1 output reaches 145,089 GEO, surpassing half of its 2026 guidance as steady Q2 production keeps the miner on track for its 2026 target.
Zacks
DD Enhances WAVE PRO With Integrated Water Treatment Design Platform
DuPont upgrades WAVE PRO to unite four water-treatment technologies, boosting system accuracy, efficiency and flexibility for complex projects.
Zacks
AG's Q2 Silver Production Jumps 3% Y/Y, 2026 Production View Hiked
First Majestic lifts its 2026 production outlook after Q2 silver output rises 3% y/y, backed by strong mine performance and higher guidance across key assets.
Zacks
FMC Files First Global Regulatory Submission With EPA for Rimisoxafen
FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.